Harmony Biosciences Holdings Inc
HRMYHealthcare|Biotechnology|USA
$36.87
-1.38 (-3.61%)
DCF (FCF)
$50.96
Tangible Book
$14.29
Graham Number
$29.30
Earnings Power
$41.99
Clinical Trials (30)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07675135 A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy | EDS, Cataplexy | P3 | Recruiting | 258 | RCT, Double-blind | HBS-301 |
| NCT05066217 An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome | Lennox Gastaut Syndrome | P3 | Recruiting | 260 | RCT, Double-blind | Clemizole HCl, Placebo |
| NCT06366464 A Study of Pitolisant in Patients With Prader-Willi Syndrome | Prader-Willi Syndrome | P3 | Recruiting | 134 | RCT, Double-blind | Pitolisant tablet |
| NCT07500090 A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) | Idiopathic Hypersomnia | P3 | Recruiting | 248 | RCT, Double-blind | HBS-301 tablet, Placebo |
| NCT04462770 A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome | Dravet Syndrome | P3 | Recruiting | 150 | RCT, Double-blind | Clemizole HCl, Placebo |
| NCT06451978 You, Me and Nature Pilot Study | Dementia, Mild Cognitive Impairment | N/A | Active | 48 | RCT, Single-blind | — |
| NCT07520019 Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning Hair | Hair Thinning | N/A | Active | 40 | RCT, Single-blind | — |
| NCT05536011 WAKIX® (Pitolisant) Pregnancy Registry | Pregnancy Related, Narcolepsy | Recruiting | 1,329 | — | Pitolisant, Comparator Products | |
| NCT06220084 The UPbeating GReek Application of DancE in Parkinson's Disease Clinical Trial | Parkinson Disease | N/A | Active | 40 | RCT, Open-label | — |
| NCT06014281 Examining the Effects of Regular Brief Internet-based Meditation Practice on Mental Health and Well Being | Healthy, Well-Being, Psychological | N/A | Active | 300 | RCT, Open-label | — |
| NCT07047378 ACT-Based Training for Parental Burnout and Child Well-being | Child Abuse, Parental Burnout | N/A | Recruiting | 120 | RCT, Single-blind | — |
| NCT05581576 Pitolisant in Refractory Restless Legs Syndrome | Restless Legs Syndrome | P4 | Unknown | 18 | Open-label | Pitolisant |
| NCT05458128 A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia | Idiopathic Hypersomnia, Excessive Daytime Sleepiness | P3 | Completed | 119 | Open-label | Pitolisant |
| NCT05156047 A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia | Idiopathic Hypersomnia | P3 | Completed | 214 | RCT, Double-blind | Open-label pitolisant, Double-blind placebo, Double-blind pitolisant |
| NCT07219485 A Study of Pitolisant in Participants With Prader-Willi Syndrome | Prader-Willi Syndrome | P3 | By Invite | 150 | Open-label | Pitolisant |
| NCT06582277 Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836 | Vaccine-Preventable Diseases, Influenza | P2 | Completed | 117 | RCT, Double-blind | OVX836 shot |
| NCT05284799 Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers. | Influenza | P2 | Completed | 180 | RCT, Double-blind | OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Fluarix® Tetra), Placebo |
| NCT04257929 A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension | Prader-Willi Syndrome | P2 | Completed | 65 | RCT, Double-blind | Pitolisant oral tablets, Placebo oral tablet |
| NCT04886518 Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1 | Myotonic Dystrophy 1, Excessive Daytime Sleepiness | P2 | Completed | 30 | RCT, Double-blind | Pitolisant Oral Tablet, Placebo oral tablet |
| NCT05149898 Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE) | 22Q11.2 Deletion Syndrome | P2 | Completed | 20 | Open-label | ZYN002 |
| NCT07051252 A Study of HBS-201 (Pitolisant Delayed-release) | Narcolepsy | P1 | Completed | 46 | Open-label | HBS-201 |
| NCT06930872 Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates | Drug Interaction | P1 | Completed | 29 | Open-label | Part 1, Part 2 |
| NCT04055454 A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001) | Lassa Virus Infection | P1 | Completed | 60 | RCT, Double-blind | MV-LASV |
| NCT07109453 To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects | Normal, Sensitive Skin | N/A | Not Yet Recruiting | 26 | Open-label | — |
| NCT03433131 Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy | Narcolepsy Without Cataplexy, Narcolepsy With Cataplexy | NO_LONGER_AVAILABLE | — | — | Pitolisant | |
| NCT06605768 Study Evaluating the Effects of Dietary Supplement on Hair Thickness and Hair Strength in Individuals With Self-Perceived Thinning Hair | Hair Thinning | N/A | Completed | 80 | RCT, Single-blind | — |
| NCT03188302 Evaluation of New Method for Measuring Stool Consistency | Healthy | N/A | Completed | 40 | Open-label | — |
| NCT06880237 Sing Out Loud: A Choral Singing Program for Persons Living With Dementia | Dementia, Nursing Homes Residents | N/A | Completed | 26 | RCT, Open-label | — |
| NCT02791048 Music Therapy for Palliative Care Patients | Palliative Care | N/A | Completed | 51 | RCT, Single-blind | — |
| NCT06779981 A Prospective Epidemiological Study Evaluating Occurrences of Influenza-like Illness | Influenza | Completed | 119 | — | — |